IL235946B - Peptide deletions in the hairpin cell - Google Patents

Peptide deletions in the hairpin cell

Info

Publication number
IL235946B
IL235946B IL235946A IL23594614A IL235946B IL 235946 B IL235946 B IL 235946B IL 235946 A IL235946 A IL 235946A IL 23594614 A IL23594614 A IL 23594614A IL 235946 B IL235946 B IL 235946B
Authority
IL
Israel
Prior art keywords
beta
hairpin peptidomimetics
peptidomimetics
hairpin
Prior art date
Application number
IL235946A
Other languages
English (en)
Hebrew (he)
Other versions
IL235946A0 (en
Original Assignee
Polyphor Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polyphor Ag filed Critical Polyphor Ag
Publication of IL235946A0 publication Critical patent/IL235946A0/en
Publication of IL235946B publication Critical patent/IL235946B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL235946A 2012-06-06 2014-11-27 Peptide deletions in the hairpin cell IL235946B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2012/060766 WO2013182240A1 (en) 2012-06-06 2012-06-06 Beta-hairpin peptidomimetics

Publications (2)

Publication Number Publication Date
IL235946A0 IL235946A0 (en) 2015-01-29
IL235946B true IL235946B (en) 2019-06-30

Family

ID=46208596

Family Applications (1)

Application Number Title Priority Date Filing Date
IL235946A IL235946B (en) 2012-06-06 2014-11-27 Peptide deletions in the hairpin cell

Country Status (12)

Country Link
US (2) US9617308B2 (https=)
EP (1) EP2859012B1 (https=)
JP (1) JP6047231B2 (https=)
CN (1) CN104603145B (https=)
AU (1) AU2012381808B2 (https=)
CA (1) CA2875733C (https=)
ES (1) ES2647076T3 (https=)
IL (1) IL235946B (https=)
IN (1) IN2014KN02752A (https=)
MX (1) MX355396B (https=)
SG (1) SG11201407837WA (https=)
WO (1) WO2013182240A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2132221T3 (pl) 2007-02-28 2011-04-29 Polyphor Ltd Przyłączone do matrycy peptydomimetyki
JP6047231B2 (ja) * 2012-06-06 2016-12-21 ポリフォー・アクチェンゲゼルシャフトPolyphor Ag β−ヘアピンペプチド模倣薬
US9308236B2 (en) 2013-03-15 2016-04-12 Bristol-Myers Squibb Company Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
WO2016039749A1 (en) 2014-09-11 2016-03-17 Bristol-Myers Squibb Company Macrocyclic inhibitors of the pd-1/pd-l1 and cd80 (b7-1)/pd-li protein/protein interactions
US9732119B2 (en) 2014-10-10 2017-08-15 Bristol-Myers Squibb Company Immunomodulators
US9856292B2 (en) 2014-11-14 2018-01-02 Bristol-Myers Squibb Company Immunomodulators
US9861680B2 (en) 2014-12-18 2018-01-09 Bristol-Myers Squibb Company Immunomodulators
US9944678B2 (en) 2014-12-19 2018-04-17 Bristol-Myers Squibb Company Immunomodulators
US20160222060A1 (en) 2015-02-04 2016-08-04 Bristol-Myers Squibb Company Immunomodulators
US9809625B2 (en) 2015-03-18 2017-11-07 Bristol-Myers Squibb Company Immunomodulators
US10143746B2 (en) 2016-03-04 2018-12-04 Bristol-Myers Squibb Company Immunomodulators
US10358463B2 (en) 2016-04-05 2019-07-23 Bristol-Myers Squibb Company Immunomodulators
HRP20210644T8 (hr) 2016-05-19 2021-06-25 Bristol-Myers Squibb Company Imunomodulatori za pet-snimanje
CN109922818B (zh) * 2016-09-06 2024-02-20 主线生物科学公司 Cxcr4拮抗剂及使用方法
KR102526034B1 (ko) 2016-11-07 2023-04-25 브리스톨-마이어스 스큅 컴퍼니 면역조정제
EP3642220A1 (en) 2017-06-23 2020-04-29 Bristol-Myers Squibb Company Immunomodulators acting as antagonists of pd-1
KR20230145543A (ko) * 2017-09-05 2023-10-17 메인라인 바이오사이언스 고친화성 cxcr4 선택적 결합 콘쥬게이트 및 그 사용 방법
US11123437B2 (en) 2017-09-05 2021-09-21 Mainline Biosciences, Inc. Selective CXCR4 binding peptide conjugate and methods for making and using the same
CN111051332B (zh) 2017-10-03 2024-09-06 百时美施贵宝公司 免疫调节剂
EP4087857B1 (en) 2020-01-06 2023-11-01 Bristol-Myers Squibb Company Immunomodulators
JP2023516878A (ja) * 2020-01-26 2023-04-21 メインライン バイオサイエンシーズ(シャンハイ)シーオー.,エルティーディ. 同位体標識された選択的cxcr4結合性ペプチドコンジュゲート並びにその作製方法及び使用方法
KR20220161407A (ko) 2020-03-30 2022-12-06 브리스톨-마이어스 스큅 컴퍼니 면역조정제
KR20230129388A (ko) 2020-11-19 2023-09-08 스펙시스 아게 암 치료를 위한 펩타이드 cxcr4 억제제 및 탁산을 포함하는 약제학적 조합물
WO2022184320A2 (en) 2021-03-03 2022-09-09 Spexis Ag Medical use of cyclic peptides
WO2023285677A1 (en) 2021-07-16 2023-01-19 Spexis Ag Pharmaceutical combinations for treating cancer
WO2023285681A1 (en) 2021-07-16 2023-01-19 Spexis Ag Pharmaceutical combinations for treating cancer
WO2025068348A1 (en) 2023-09-27 2025-04-03 Spexis Ag Pharmaceutical combination of cxcr4 and pd-1 inhibitors for treating cancer
WO2025068346A1 (en) 2023-09-27 2025-04-03 Spexis Ag Pharmaceutical combination of cxcr4, pd-1 and fak inhibitors for treating cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212288A (en) * 1990-02-20 1993-05-18 Syntex (U.S.A.) Inc. Temporary minimal protection synthesis of serine-containing polypeptides
WO2004096839A1 (en) * 2003-05-02 2004-11-11 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
US8628750B2 (en) * 2006-02-27 2014-01-14 Technische Universitat Munchen Cancer imaging and treatment
PL2132221T3 (pl) * 2007-02-28 2011-04-29 Polyphor Ltd Przyłączone do matrycy peptydomimetyki
EP2427476B1 (en) * 2009-05-07 2018-08-08 Polyphor Ag Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
WO2011066869A1 (en) * 2009-12-04 2011-06-09 Polyphor Ag Beta-hairpin peptidomimetics
CN103703018B (zh) * 2011-06-07 2016-10-26 波利弗尔股份公司 作为CXC4拮抗剂的β-发夹肽模拟物
JP6047231B2 (ja) * 2012-06-06 2016-12-21 ポリフォー・アクチェンゲゼルシャフトPolyphor Ag β−ヘアピンペプチド模倣薬

Also Published As

Publication number Publication date
CN104603145B (zh) 2018-05-18
US20170165319A1 (en) 2017-06-15
US9617308B2 (en) 2017-04-11
CA2875733C (en) 2019-09-10
HK1207867A1 (en) 2016-02-12
US20150218219A1 (en) 2015-08-06
IN2014KN02752A (https=) 2015-05-08
WO2013182240A1 (en) 2013-12-12
JP6047231B2 (ja) 2016-12-21
SG11201407837WA (en) 2014-12-30
CA2875733A1 (en) 2013-12-12
MX2014014840A (es) 2015-02-12
US10363284B2 (en) 2019-07-30
EP2859012B1 (en) 2017-08-09
ES2647076T3 (es) 2017-12-19
EP2859012A1 (en) 2015-04-15
NZ702470A (en) 2016-12-23
IL235946A0 (en) 2015-01-29
JP2015521204A (ja) 2015-07-27
MX355396B (es) 2018-04-18
AU2012381808B2 (en) 2017-04-27
CN104603145A (zh) 2015-05-06
AU2012381808A1 (en) 2015-01-22

Similar Documents

Publication Publication Date Title
IL235946B (en) Peptide deletions in the hairpin cell
ZA201407694B (en) Substituted pyrrolidine-2-carboxamides
DK2830816T3 (en) Hidtil ukendt coatingkoncept
DK3327112T3 (en) Agse-deficient stamme
SG11201404344XA (en) Substituted pyrrolidine-2-carboxamides
EP2857033A4 (en) PEPTIDE WITH SKIN PERMEATION
GB201213567D0 (en) Biomarkers
EP2935220A4 (en) PERI-carbinol
IL233059A0 (en) Synthetic Wakanjin
ZA201507428B (en) Beta-hairpin peptidomimetics
IL229535B (en) Cell peptidomimetics as 4cxc antagonists
IL237636A0 (en) new uses
EP2934541A4 (en) NORIBOGAINE SUBSTITUTE
EP2920142A4 (en) MÉTHANOFULLERRÈNES
ZA201507350B (en) Beta-hairpin peptidomimetics
GB2501937B (en) Capability reporting
EP2803993A4 (en) AUTOMATIC SAMPLER
GB201210565D0 (en) Biomarkers
GB201200555D0 (en) Peptide
IL233171A0 (en) A derivative of sitaxantan
SG2013057575A (en) Refrigerator-freezer
GB201223114D0 (en) Novel peptide
PL2631512T3 (pl) Pierścień uszczelniający
EP2891663A4 (en) PEPTIDE DERIVED FROM PSF1
GB201304493D0 (en) Not published

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed